Funded Startups in Longmont
Across the 12 most recent Longmont-funded rounds shown here, disclosed deal sizes cluster tightly at the low-to-mid single-digit millions, except for Scyth…
Across the 12 most recent Longmont-funded rounds shown here, disclosed deal sizes cluster tightly at the low-to-mid single-digit millions, except for Scythe’s $23M (2025-06-11, Series Unknown), which is the only disclosed round above $20M and is well above the next-largest disclosed amounts ($20M for Fermyon Technologies on 2022-10-24; $8M for Kromatid on 2025-08-20). Sector-wise, biotechnology shows up 3 times (Kromatid $8M on 2025-08-20; Beryl Therapeutics $250K on 2023-05-18; plus Scythe is categorized as Hardware, while CleanRobotics is AI), indicating a biotech presence alongside hardware (Fermyon Technologies $20M in 2022-10-24; Scythe $23M in 2025-06-11; Burlywood $2M in 2022-04-18). Dates span 2020-09-02 (Honcho; $4M, stage blank) through 2025-08-20 (Kromatid; $8M), with multiple events concentrated in 2025 (GoodLove Foods on 2025-03-08 at $150K; Scythe on 2025-06-11 at $23M; ForCast Orthopedics on 2025-08-05 at $4M; Kromatid on 2025-08-20 at $8M).
Most recent rounds
12 shownRelated listings
Frequently asked
What stands out in disclosed round sizes for Longmont, and how extreme is it?
Scythe’s $23M (2025-06-11, Series Unknown) is the highest disclosed amount in the 12-row view, sitting above the next-largest disclosed rounds: Fermyon Technologies’ $20M (2022-10-24, Series A) and Kromatid’s $8M (2025-08-20, Series C).
How concentrated are deals in the most recent period covered by the list?
Four of the 12 rows fall in 2025: GoodLove Foods ($150K on 2025-03-08), Scythe ($23M on 2025-06-11), ForCast Orthopedics ($4M on 2025-08-05), and Kromatid ($8M on 2025-08-20).
Are any sectors over-represented among these 12 Longmont entries?
Biotechnology appears in 3 entries (Kromatid, 2025-08-20, $8M; Beryl Therapeutics, 2023-05-18, $250K; and another biotech-labeled row among the 12), while hardware also clusters with multiple entries including Scythe ($23M, 2025-06-11), Fermyon Technologies ($20M, 2022-10-24), and Burlywood ($2M, 2022-04-18).
What does the stage mix look like, especially around ‘Series Unknown’ entries?
Stage labels are often missing or labeled as ‘Series Unknown’: Scythe is ‘Series Unknown’ at $23M (2025-06-11), Medicine Horse is ‘Series Unknown’ at $60K (2023-08-14), Beryl Therapeutics is ‘Series Unknown’ at $250K (2023-05-18), and CleanRobotics and others also show explicit stages where provided (e.g., ForCast Orthopedics $4M, Series A on 2025-08-05).
Are there notable low-disclosed outliers at the bottom end of this snapshot?
GoodLove Foods’ $150K (2025-03-08, Angel) is the smallest disclosed amount in the 12 rows, and it is far below the next-lowest disclosed figure of $250K for Beryl Therapeutics (2023-05-18).
Do any entries suggest a hardware-heavy pattern across time rather than a one-off?
Hardware appears repeatedly across different years and sizes, including Burlywood ($2M, 2022-04-18), Fermyon Technologies ($20M, 2022-10-24), and Scythe ($23M, 2025-06-11), indicating more than a single hardware event within the date window shown.
Know which startups just got funded. Every week.
Fresh funding rounds, new companies, and the sectors moving fastest — in your inbox every Monday morning.
Free. Sent every Monday. Unsubscribe anytime.